Skip to main content

Month: March 2020

CloudMD Appoints Mark W. Kohler to Board of Directors

VANCOUVER, British Columbia, March 19, 2020 (GLOBE NEWSWIRE) — CloudMD Software & Services Inc. (CSE: DOC, OTCQB: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), a Company focused on revolutionizing the delivery of healthcare, is pleased to announce the appointment of Mark W. Kohler to the board of directors.Mark has over 32 years of experience as an entrepreneur, financial executive, board member, and investor at leading North American healthcare, technology, and financial services companies. He currently leads Exelerate Inc., a strategic advisory group specializing in corporate development and strategy, M&A, and growth capital funding. He was recently the Executive Chairman at QHR Corporation where he led the Board and management through the profitable transformation and strategic re-alignment of its healthcare businesses...

Continue reading

VitalHub Announces Deployment of Patient Flow Solution to Support the Management of the COVID-19 Pandemic in Windsor and Essex County (Southwestern Ontario)

TORONTO, March 19, 2020 (GLOBE NEWSWIRE) — VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) announced today that it will be deploying its patient flow solution, utilizing its Oculys Performance technology, for five hospitals in Windsor and Essex County to assist them in their efforts to plan for and manage patient flow in the face of a possible COVID-19 pandemic.This announcement comes on the heels of an additional request that the Company had received from its clients to assist them in preparing their hospitals for the creation and implementation of assessment centres – to accommodate the anticipated influx of patients being assessed and treated for COVID-19.The configuration of the Oculys solution has started and will be deployed immediately, beginning with updating the configurations to provide real-time and accurate...

Continue reading

Plus Products Releases Letter from CEO Discussing COVID-19 and Strategic Changes

SAN MATEO, Calif., March 19, 2020 (GLOBE NEWSWIRE) — Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) (“PLUS” or the “Company”), a leading branded cannabis products company based in California, today released a letter from Jake Heimark, Co-founder and CEO, discussing the COVID-19 pandemic and recent company developments.To our Shareholders:I could not be prouder of the PLUS team over the past few weeks. This is an unprecedented time for the world, and I continue to be amazed at the care, passion and commitment of our team to provide high quality products to as many customers as possible.We do not know how COVID-19 will affect our business, but we believe that we are well prepared to respond to this crisis. For our company’s full response and real-time updates on the actions we are taking to respond to this crisis, please visit plusproductsinc.com/coronavirus.PLUS...

Continue reading

NexTech AR to Present at Wall Street Reporter’s NEXT SUPER STOCK – Live Stream Event on March 19, 2020

NEW YORK and TORONTO, March 19, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), the leader in augmented reality for e-commerce and AR learning applications, announced today that Evan Gappelberg CEO, will present an update on recent developments, as well as an overview of upcoming milestones anticipated in 2020 at Wall Street Reporter’s NEXT SUPER STOCK – live stream event on Thursday, March 19, 2020 at 1:00 p.m. ET / 10:00 a.m. PT.Date: Time: Access:Thursday, March 19, 20201:00 p.m. ET / 10:00 a.m. PThttps://register.gotowebinar.com/register/1877154826306369292The livestream presentation will be archived for 30 days and participants are encouraged to go to the above-referenced website 10 minutes prior to the start of the presentation. For anyone unable to attend, a video will be posted...

Continue reading

Tietoa koronavirusepidemian vaikutuksesta Rauten 31.3.2020 pidettävään yhtiökokoukseen

RAUTE OYJ PÖRSSITIEDOTE 19.3.2020 KLO 13.30TIETOA KORONAVIRUSEPIDEMIAN VAIKUTUKSESTA RAUTEN 31.3.2020 PIDETTÄVÄÄN YHTIÖKOKOUKSEENRauten varsinainen yhtiökokous pidetään suunnitellusti Lahdessa 31.3.2020 klo 18.00.Osakkeenomistajiemme ja henkilöstömme terveys on meille ensisijaisen tärkeää tämän koronavirusepidemian aikana. Minimoidaksemme epidemian aiheuttamat sosiaalisiin kontakteihin liittyvät terveysriskit yhtiökokouksemme osalta ja noudattaaksemme viranomaisten antamia määräyksiä ja ohjeita, teemme yhtiökokouksen suhteen seuraavat poikkeusjärjestelyt.Vallitsevissa olosuhteissa Raute pyrkii pitämään yhtiökokouksen mahdollisimman lyhyenä kuitenkin siten, että yhtiökokouskutsussa mainitut asiat tulevat riittävällä tavalla käsiteltyä ja yhtiökokous on juridisesti päätösvaltainen.Tästä johtuen yhtiökokouskutsusta poiketen ilmoittautuneiden...

Continue reading

Information about Raute’s Annual General Meeting on March 31, 2020 with regards to the coronavirus epidemic

RAUTE CORPORATION STOCK EXCHANGE RELEASE 19 MARCH 2020 at 1:30 p.m.Our shareholders’ and personnel’s health is of utmost importance to us during this coronavirus epidemic. In order to minimize epidemic health risks related to social contacts considering our AGM and to comply with the regulations and instructions given by the authorities, we will make the following special arrangements as to the AGM. In the prevailing circumstances, Raute’s target is to keep the AGM as short as possible while, however, making sure that all items of the notice to the AGM will be considered in an adequate way and the AGM fulfills all legal requirements. Based on this and in deviation from the notice to the AGM, reception of the registered participants and distribution of ballots will begin only at 5:45 p.m., and no refreshments will be served after the meeting. Those...

Continue reading

Marinus Pharmaceuticals Appoints Sasha Damouni Ellis as Vice President, Investor Relations and Corporate Communications

RADNOR, Pa., March 19, 2020 (GLOBE NEWSWIRE) — Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat orphan seizure disorders, today announced the appointment of Sasha Damouni Ellis as Vice President, Investor Relations and Corporate Communications, reporting to Scott Braunstein, M.D., Chief Executive Officer of Marinus. In this role, Ms. Damouni Ellis will lead strategic investor relations and communications programs, and will work closely with investors, employees, advocacy groups, patient organizations and the media.“As we build on our recent clinical success to strategically develop ganaxolone in orphan seizure disorders, the addition of Sasha to the Marinus team significantly strengthens our capabilities to enhance relationships with key stakeholders,”...

Continue reading

Major Shareholders Extend Working Capital Facility to Continue Support for the Marimaca Project

VANCOUVER, British Columbia, March 19, 2020 (GLOBE NEWSWIRE) — Coro Mining Corp. (“Coro” or the “Company”) (TSX: COP) today announced that it has entered into an unsecured working capital facility (“WCF”) with its major shareholders, Greenstone Resources II LP (“Greenstone”), and Tembo Capital Mining Fund II LP (“Tembo”) (together “the Lenders”), pursuant to which the Lenders have agreed to lend up to US$6.0 million to Coro to fund the Company through these challenging times.The WCF has a 12-month term from the date of closing and bears interest at 12% per annum. Greenstone and Tembo will receive an aggregate 3% arrangement fee under the WCF, which will be payable at maturity. The proceeds of the WCF will allow Coro to continue its exploration and development plans, in a measured fashion, for its flagship Marimaca Copper Project...

Continue reading

Zai Lab Announces Financial Results for Full Year Ended December 31, 2019 and Corporate Updates

— Company to Host Conference Call and Webcast Today at 8:30 a.m. EDTSHANGHAI, China and SAN FRANCISCO, March 19, 2020 (GLOBE NEWSWIRE) — Zai Lab Limited (NASDAQ: ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, today announced financial results for the twelve months ended December 31, 2019 and corporate updates.“Coinciding with the celebration of our five-year anniversary, 2019 was a year of many important achievements for Zai Lab,” said Dr. Samantha Du, Founder and Chief Executive Officer of Zai Lab. “Some key milestones achieved include the marketing approval obtained for ZEJULA® in China and our submissions for regulatory approval in China for Optune® and omadacyline in China. We also entered into licensing collaborations with Deciphera and Incyte, expanded our commercial platform in...

Continue reading

HighPoint Resources Provides Update on Development Program

DENVER, March 19, 2020 (GLOBE NEWSWIRE) — HighPoint Resources Corporation (“we”, “us”, or the “Company”) (NYSE: HPR) announced today an update to its 2020 development program, liquidity and hedges. Today’s update takes into account the recent significant decrease in crude oil prices, and includes the following:             All drilling and completion activity that is currently in progress will be completed, and all new planned activity will be deferred; this will not impact first half of 2020 production volumesMaintain flexibility to adjust capital program further based on market conditionsStrong hedge position protects 2020 cash flow and has a current mark-to-market value of approximately $225 millionStill anticipate generating positive free cash flow in 2020Anticipate reducing bank debt by approximately $45 million during the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.